These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2965461)

  • 1. Prevention of horizontal transmission of hepatitis B: efficacy of hepatitis B immunoglobulin and vaccine in an institution for the handicapped.
    Ueda K; Tokugawa K; Hashiguchi Y; Matsumoto S; Uchimura H; Shigaki T; Ishihara Y; Mizuno K; Tashiro A; Nonaka S
    Vaccine; 1988 Feb; 6(1):54-8. PubMed ID: 2965461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of hepatitis B immunization on prevention of mother-to-infant transmission of hepatitis B virus and on the immune response of infants towards hepatitis B vaccine.
    Zhang L; Gui XE; Teter C; Zhong H; Pang Z; Ding L; Li F; Zhou Y; Zhang L
    Vaccine; 2014 Oct; 32(46):6091-7. PubMed ID: 25240752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune response to hepatitis B vaccine in infants and newborns: control trial in an endemic area (Senegal).
    Coursaget P; Deciron F; Tortey E; Barin F; Chiron JP; Yvonnet B; Diouf C; Denis F; Diop-Mar I; Correa P
    IARC Sci Publ; 1984; (63):319-35. PubMed ID: 6242150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective efficacy of a recombinant deoxyribonucleic acid hepatitis B vaccine in institutionalized mentally handicapped clients.
    Van Damme P; Vranckx R; Safary A; André FE; Meheus A
    Am J Med; 1989 Sep; 87(3A):26S-29S. PubMed ID: 2528294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination against hepatitis B virus infection in neonates.
    Pongpipat D; Suvatte V; Assateerawatts A
    Helv Paediatr Acta; 1984 Aug; 39(3):231-6. PubMed ID: 6242403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevention of perinatal transmission of hepatitis B virus infection by HB-Ig and HB-vaccine].
    Ohryohji F; Umezu T; Ootsuka M; Kanda S
    Fukuoka Igaku Zasshi; 1984 Oct; 75(10):594-7. PubMed ID: 6240438
    [No Abstract]   [Full Text] [Related]  

  • 7. Active pre-exposure immunisation against hepatitis B virus: immunogenicity of hepatitis B vaccine in healthy Thai adults and children.
    Pongpipat D; Suvatte V; Assateerawatts A; Bhethraratt S
    Asian Pac J Allergy Immunol; 1987 Jun; 5(1):63-5. PubMed ID: 2956961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Respective importance of vertical and horizontal transmission of hepatitis B in the Australian archipelago (French Polynesia). Preliminary results of the vaccination of newborns].
    Boutin JP; Spiegel A; Flye Sainte-Marie F; Cartel JL; Girard M; Saliou P; Roux J
    Bull Soc Pathol Exot; 1991; 84(5 Pt 5):906-11. PubMed ID: 1840244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Results of vaccination with the hepatitis B vaccine in patients and personnel at the Hemodialysis Center in Karlovac].
    Palmović D; Vitas B; Doko A; Belavić Z; Racki L
    Lijec Vjesn; 1989 Nov; 111(11):400-4. PubMed ID: 2534601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immune response to hepatitis B vaccine and duration of protection in a dialysis unit].
    Magnani G; Calzetti C; Campari M; Lehndorff H; Pizzaferri P; Rossi E
    Acta Biomed Ateneo Parmense; 1987; 58(1-2):41-7. PubMed ID: 2960120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antibody responses in human being to pre-S2 and related hepatitis B virus-envelope antigens in vivo and in vitro].
    Ogata M; Ishikawa H; Kato Y; Honta S; Yoshida H; Yasuda H; Ohto H; Watanabe N
    Rinsho Byori; 1991 Jan; 39(1):3-13. PubMed ID: 1826138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effectiveness and tolerance of genetically engineered vaccines for hepatitis B--a comparative study].
    Schmid K; Strebl H; Heck KJ; Weltle D; Raithel HJ
    Gesundheitswesen; 1992 May; 54(5):219-22. PubMed ID: 1535816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of immune potentiation by complexing HBsAg in a heat-inactivated hepatitis B vaccine with antibody in hepatitis B immunoglobulin.
    Lelie PN; van Amelsfoort PJ; Martine de Groot CS; Bakker E; Schaasberg W; Niessen JC; Reesink HW
    Hepatology; 1989 Jul; 10(1):36-8. PubMed ID: 2737602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intramuscular versus low-dose intradermal hepatitis B vaccine. Assessment by humoral and cellular immune response to hepatitis B surface antigen.
    Frazer IH; Jones B; Dimitrakakis M; Mackay IR
    Med J Aust; 1987 Mar; 146(5):242-5. PubMed ID: 2950303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired response to recombinant hepatitis B vaccine in HIV-infected persons.
    Bruguera M; Cremades M; Salinas R; Costa J; Grau M; Sans J
    J Clin Gastroenterol; 1992 Jan; 14(1):27-30. PubMed ID: 1532609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of hepatitis B virus carrier state in infants according to maternal serum levels of HBV DNA.
    Ip HM; Lelie PN; Wong VC; Kuhns MC; Reesink HW
    Lancet; 1989 Feb; 1(8635):406-10. PubMed ID: 2563788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mass vaccination against hepatitis B in preschool children: immunogenicity after three reduced doses.
    Milne A; Moyes CD; Waldon J; Pearce NE; Krugman S
    N Z Med J; 1989 Aug; 102(874):429-30. PubMed ID: 2527346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anamnestic response to hepatitis B vaccine in nonalcoholic liver cirrhosis patients with and without HBV-DNA.
    Baruch Y; Enat R; Gershoni-Baruch R; Rimon N; Ben-Porath E
    Am J Gastroenterol; 1992 May; 87(5):613-6. PubMed ID: 1534439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity and protective efficacy of low dose recombinant DNA hepatitis B vaccine in normal and high-risk neonates.
    Assateerawatt A; Tanphaichitr VS; Suvatte V; In-ngarm L
    Asian Pac J Allergy Immunol; 1991 Dec; 9(2):89-93. PubMed ID: 1839654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistence of anti-HBs after intradermal inoculation of reduced doses of hepatitis B vaccine.
    Zoulek G; Lorbeer B; Jilg W; Deinhardt F
    Lancet; 1984 Oct; 2(8409):983-4. PubMed ID: 6149374
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.